Product
MTPS9579A
2 clinical trials
2 indications
Indication
Chronic Spontaneous UrticariaIndication
AsthmaClinical trial
A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Pilot and Dose-Ranging Study of MTPS9579A in Participants With Refractory Chronic Spontaneous UrticariaStatus: Withdrawn, Estimated PCD: 2024-07-31
Clinical trial
A Phase IIa, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MTPS9579A in Patients With Asthma Requiring Inhaled Corticosteroids and a Second ControllerStatus: Completed, Estimated PCD: 2022-05-19